Tag: Andrew Gwynne

  • Andrew Gwynne – 2024 Statement on Respiratory Syncytial Virus Immunisation Programmes

    Andrew Gwynne – 2024 Statement on Respiratory Syncytial Virus Immunisation Programmes

    The statement made by Andrew Gwynne, the Parliamentary Under-Secretary of State for Health and Social Care, in the House of Commons on 18 July 2024.

    I am today confirming that the new immunisation programme to protect infants, with a vaccine during pregnancy, and older adults against respiratory syncytial virus will start this September.

    RSV is a common respiratory virus that usually causes mild cold-like symptoms but can cause severe illness, especially for young infants and older adults. There is a significant burden of RSV illness in the UK population which greatly impacts NHS services during the winter months. RSV accounts for over 30,000 hospital admissions for children under five and is estimated to cause around 9,000 admissions among adults over the age of 75 each year. The programme could free up thousands of hospital bed days and help to prevent hundreds of deaths each year.

    In June 2023, the Joint Committee on Vaccination and Immunisation advised that an RSV immunisation programme that is cost-effective should be developed to protect both infants and older adults. From September, a routine programme will begin in England for those turning 75 and for pregnant women, who will be offered vaccination from 28 weeks of pregnancy until full term to protect their baby during the first months of life when they are most vulnerable to RSV. A one-off campaign will also run from September 2024 until 31 August 2025 for all older adults aged 75 to 79 years old on 1 September 2024.

    The UK Health Security Agency is now working rapidly with the NHS to ensure we are ready, in September, to deliver the UK’s first RSV vaccination programme. The programme will save lives and protect people most at risk. We are delighted that the RSV vaccination programme will begin soon across all four UK nations.

    His Majesty’s Government are encouraging eligible members of the population to come forward for their vaccination when they have been invited to do so by the NHS, to protect those most vulnerable to RSV illness and to reduce NHS winter pressures.

    Older adults will be invited to come forward when they turn 75 and will be able to book their vaccination appointment with their GP.

    Older adults aged 75 to 79 years old on 1 September 2024 will be invited to receive their RSV vaccination with their GP in a timely manner to ensure as many people as possible are protected this winter.

    Those that are at least 28 weeks pregnant should speak to their maternity service or GP surgery to get the vaccine to protect their baby.

  • Andrew Gwynne – 2023 Speech on Prescription Charges for People Aged 60 or Over

    Andrew Gwynne – 2023 Speech on Prescription Charges for People Aged 60 or Over

    The speech made by Andrew Gwynne, the Labour MP for Denton and Reddish, in Westminster Hall, the House of Commons on 6 March 2023.

    It is a pleasure to serve under your chairmanship, Sir Edward. I want to start by thanking the Petitions Committee for facilitating this debate, and my hon. Friend the Member for Gower (Tonia Antoniazzi) for the passionate way in which she put forward the arguments of Peter, Denise and many others who find themselves in the predicament of having to pay for prescriptions or who worry that they might have to pay for them as pensioners.

    It is a pleasure to respond to the debate on behalf of the shadow Health and Social Care team, but also as the Member of Parliament for Denton and Reddish, and I know that many of my constituents are concerned about this potential policy change. As we have heard, we are in the middle of a cost of living crisis, when many people face unsustainable rises in their energy and household bills. It is little surprise that the Government’s decision to consult on scrapping free NHS prescriptions for the over-60s will be of profound concern to many people already struggling to make ends meet. That anxiety has been compounded by characteristic delay from the Department of Health and Social Care.

    The Government first announced the consultation to scrap free NHS prescriptions for the over-60s in July 2021, meaning that there was little or no time for Members of this House to sufficiently scrutinise the proposals before that year’s summer recess. The consultation closed in September 2021 and, two and a half years on, we are still none the wiser about where the Government are on the issue.

    A quick glance at written parliamentary questions shows that many Members from across the House have asked the Government for clarity, only to receive a boilerplate response that an announcement would be made “in due course”. In his response, will the Minister set out precisely when that announcement will be made and why there has been such a delay in the Government addressing their own consultation?

    That is important, because the Government’s own impact assessment raises several potential problems with the proposals. Notably,

    “some people towards the lower end of the income distribution may struggle to afford all their prescriptions”,

    which can result in

    “future health problems for the individual and a subsequent cost to the NHS.”

    That is precisely the point made in their interventions by my hon. Friends the Members for Gower and for Coventry North West (Taiwo Owatemi) and, indeed, the hon. Member for Rutherglen and Hamilton West (Margaret Ferrier), who is not in her place. Therefore, if the Government do decide to opt for this policy, we need to know what steps they will take to support people—especially those over 60 and with long-term conditions—with their prescription fees.

    Prescription charges have already increased by 30% since 2010 and, given the financial context we are in, there are really valid concerns about people being priced out of accessing vital medicines. The Royal Pharmaceutical Society recently conducted a survey of 269 pharmacies, with half of respondents saying that patients were asking them which medicines they could do without. Half of pharmacies surveyed also said that they have seen a rise in people not collecting their prescriptions at all. That is incredibly concerning.

    Last year, Asthma & Lung UK found that 15% of surveyed people with respiratory conditions were rationing the use of their inhalers to make them last longer. Some 5% of people said they were being forced to borrow medicine from others, which really frightens me, because someone’s prescription is pertinent to them and them alone. I had hoped that we had moved away from a world where we lend medicines to others. Frankly, these statistics should be ringing alarm bells in the Department of Health and Social Care and, for that matter, in the Department for Work and Pensions, but unfortunately we have had radio silence.

    I would like to impress on the Minister the simple fact that if people are not taking vital medication, they could be living in extreme pain, and in some cases they will be at risk of serious medical complications as well. Have the Minister and his officials made any assessment of the number of people in England who are currently unable to afford medicine, and of the knock-on impact on NHS services, which are already at breaking point thanks to this Government’s mismanagement of the NHS?

    Last year, the Government froze prescription charges in a move that was welcome to many in England. The next review is due to take effect in April, and I am sure I do not need to remind the Minister that that will come at the same time as the implementation of Ofgem’s new energy price cap. Will the Minister provide an update on that review? Does he anticipate another rise in the cost of prescription charges, or will the Government do the right thing and freeze them again, for another year?

    While he is at it, perhaps the Minister will also nudge his colleagues in the Treasury to do the decent thing and implement a proper windfall tax on energy and gas giants to extend energy support, so that those on the lowest incomes are protected against astronomical price rises. In the 21st century, here in the United Kingdom, no one should be forced to choose between accessing vital medication, heating their home or feeding their family.

    The final point I wish to make is connected to this issue. The Government seem to have no vision or appetite to prioritise preventive public health. In the context of an ageing population, it is important that we build healthier communities. That is important not only morally, but practically, especially if we want to reduce reliance on prescriptions and primary care. What steps is the Minister taking to prioritise preventive health? On that note, will he set out why the public health grant allocation has still not been announced for local authorities in England? Many local authorities that have already set their budgets still do not know what their public health grant allocations will be in three and a half weeks’ time.

    The next Labour Government will give the NHS the tools, staff and technology it needs to treat patients on time and to put prevention right at the heart of everything it does. Coming back to the issue before the Chamber, I really hope that the Government understand the concern, worry and anxiety of those over 60 in England, who are concerned that their free prescriptions may come to an end.

    I want to mention my right hon. Friend the Member for Wentworth and Dearne (John Healey), who was here at the start of proceedings. As a member of the shadow Cabinet, he cannot take part in these deliberations, but he wanted me to highlight some of the work he has done in his constituency. He and his local team collected signatures against the proposed scrapping of free prescriptions for the over-60s. His story can be told 650 times over to the Minister, because there are elderly people across England who are concerned about this issue and who want answers from Ministers. They want their concerns to be heeded, they want assurances that the Government get the reason why prescriptions are free for the over-60s and they want the Government to understand why it is important that that remains the case. They also want to know that the Government are on their side on this issue, that their free prescriptions are not at risk and that we will not face people who cannot afford their medication with the dilemma of whether to heat their homes, feed their families or get the medication they so desperately need. Britain is better than that, and I hope the Minister has some positive news for us.

  • Andrew Gwynne – 2015 Parliamentary Question to the Department of Health

    Andrew Gwynne – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Andrew Gwynne on 2015-10-28.

    To ask the Secretary of State for Health, pursuant to the Answer of 14 October 2015 to Question 11110, how much the NHS spent on cancer services in each year since 2012-13; and what the year-on-year change in that amount was in real terms.

    Jane Ellison

    Overall National Health Service expenditure on cancer services is not available for 2013-14 or 2014-15. NHS England has published clinical commissioning group (CCG) level expenditure on cancer for 2013-14, which was estimated to be £2.8 billion. CCGs are currently in the process of preparing estimates of expenditure for cancer services in 2014-15.

    CCG expenditure is a proportion of overall NHS expenditure, as NHS England commissions some cancer services directly. NHS England is currently reviewing the data on direct commissioning expenditure and plans to publish this when finalised.

  • Andrew Gwynne – 2015 Parliamentary Question to the Ministry of Justice

    Andrew Gwynne – 2015 Parliamentary Question to the Ministry of Justice

    The below Parliamentary question was asked by Andrew Gwynne on 2015-11-02.

    To ask the Secretary of State for Justice, what estimate he has made of the value of stationery that has been (a) lost and (b) stolen from his Department in each of the last five fiscal years; and what the cost was of replacing such stationery.

    Mr Shailesh Vara

    The information requested could only be obtained at disproportionate cost.

  • Andrew Gwynne – 2015 Parliamentary Question to the Department of Health

    Andrew Gwynne – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Andrew Gwynne on 2015-11-24.

    To ask the Secretary of State for Health, what estimate he has made of the (a) forecast reduction in cases of and deaths from infection by Group C meningococcal disease as a result of the introduction of the meningitis C vaccine to the UK schedule in 1999, (b) number of meningitis C vaccinations administered in each year since that programme began and (c) cost of delivering that programme in each year since 1999.

    Jane Ellison

    Deaths have fallen from 110 in 1998/99 to an annual average of 3 deaths over the last 10 years. Annual MenC cases and deaths have therefore been respectively 97% and 96% lower in the last 10 years than in the year before vaccination was available.

    Routine immunisation programmes with MenC containing vaccines have changed since 1999 and this has affected the ability to collect estimate annual numbers of doses administered for each vaccine offered but currently around 96% of infants receive MenC vaccine and 93% of one year olds receive their MenC-Hib booster in England by their second birthday. Coverage data are not routinely collected on the third dose in adolescence (currently MenACWY vaccine) which began in the 2013-2014 school year.

    The administrative costs for the MenC programme are included in the global sum payment to general practitioners (managed by NHS England) which covers the costs of providing essential and additional primary care services.

  • Andrew Gwynne – 2016 Parliamentary Question to the Department of Health

    Andrew Gwynne – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Andrew Gwynne on 2015-12-17.

    To ask the Secretary of State for Health, if he will maintain patient access to technologies considered through commissioning through evaluation programmes during that evaluation.

    George Freeman

    There are two main phases for any treatments entered into NHS England’s Commissioning through Evaluation (CtE) programme.

    During the first phase, an agreed number of patients are recruited to the scheme within just a few participating centres across England. This enables patients to benefit from the skills and expertise in each centre, within an evaluation programme, whilst detailed clinical and patient experience data are collected.

    Once the total number of patients have been treated, the scheme enters an analysis phase. Whilst any patients already treated under the scheme will continue to receive appropriate follow up care, no new patients will be funded by NHS England during the analysis phase.

    This ensures that NHS England directs the majority of public funds to evidence based care and also means that dedicated CtE programme funding can then be redirected to support patient recruitment in another area of specialised care where further evaluation data is needed.

    This represents a continuation of NHS England’s published policy position for the treatment concerned (i.e. that the treatment is not routinely commissioned by the National Health Service).

  • Andrew Gwynne – 2016 Parliamentary Question to the Department for Work and Pensions

    Andrew Gwynne – 2016 Parliamentary Question to the Department for Work and Pensions

    The below Parliamentary question was asked by Andrew Gwynne on 2016-01-14.

    To ask the Secretary of State for Work and Pensions, what projects his Department plans to fund through the £40 million allocated to the Health and Work Innovation Fund.

    Priti Patel

    The Work and Health innovation fund will be used to build an evidence base for what works to improve employment and health outcomes.

    This evidence base will enable the Work and Health Unit to develop proposals for Longer Term reform across Work and health Systems The Unit is currently working with partners including NHS England to develop these proposals.

  • Andrew Gwynne – 2016 Parliamentary Question to the Ministry of Defence

    Andrew Gwynne – 2016 Parliamentary Question to the Ministry of Defence

    The below Parliamentary question was asked by Andrew Gwynne on 2016-01-27.

    To ask the Secretary of State for Defence, whether his Department has an insurance policy in place for civilian residents on the land around RAF Northolt to cover possible damage to their properties.

    Mark Lancaster

    The Ministry of Defence does not purchase insurance policies in the UK but accepts its own risks and acts as its own insurer.

  • Andrew Gwynne – 2016 Parliamentary Question to the Department of Health

    Andrew Gwynne – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Andrew Gwynne on 2016-01-28.

    To ask the Secretary of State for Health, what the budget was for the Rare and Imported Pathogens Laboratory in each of the last five years.

    Jane Ellison

    Public Health England (PHE) was formed on 1 April 2013; below are budgets for the Rare and Imported Pathogens Laboratory (RIPL) for each year since PHE’s formation. The RIPL was previously part of the Health Protection Agency, whose functions transferred to PHE.

    2013/14 (Actual)

    2014/15 (Actual)

    2015/16 (Budget)

    £3,491,300

    £3,667,600

    £3,465,300

  • Andrew Gwynne – 2016 Parliamentary Question to the Department of Health

    Andrew Gwynne – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Andrew Gwynne on 2016-02-02.

    To ask the Secretary of State for Health, whether the Prime Minister has seen a draft childhood obesity strategy document.

    Jane Ellison

    As part of the development of the Childhood Obesity Strategy, the Secretary of State has regular meetings to discuss its content. The Childhood Obesity Strategy will be published shortly.